2029 and Clinic - Chiropractic Pulse

OrthoPreserve Receives Both FDA Breakthrough Device Designation and Prestigious TAP Enrollment for Meniscus Implant to Revolutionize Knee Pain Treatment

OrthoSpineNews

JANUARY 29, 2025

” OrthoPreserve hopes to launch their Pilot clinical trial in 2026, while aiming for potential FDA approval by 2029. . “The anatomical design of the implant restores the normal stabilization and cushioning functions of the meniscus to relieve symptoms and preserve knee joint health.” About OrthoPreserve, Inc.

Knee Pain

Knee Pain Treatment Joints Clinic

Spinal Implants Market to Grow by USD 3.55 Billion from 2025-2029, Driven by Rising Spinal Disorder Prevalence, AI’s Impact on Market Trends – Technavio

OrthoSpineNews

FEBRUARY 10, 2025

billionfrom 2025-2029, according to Technavio. Explore trends, segmentation, and growth drivers- View Free Sample PDF Spinal Implants Market Scope Report Coverage Details Base year 2024 Historic period 2019 – 2023 Forecast period 2025-2029 Growth momentum & CAGR Accelerate at a CAGR of 5.3% Market growth 2025-2029 USD 3554.5

Degenerative Disc Disease

Degenerative Disc Disease Scoliosis Clients Spine

OrthoPreserve Receives Both FDA Breakthrough Device Designation and Prestigious TAP Enrollment for Meniscus Implant to Revolutionize Knee Pain Treatment

Spinal Implants Market to Grow by USD 3.55 Billion from 2025-2029, Driven by Rising Spinal Disorder Prevalence, AI’s Impact on Market Trends – Technavio

Stay Connected